Sterling
Sanofi logo
Sanofi
BioNTech logo
BioNTech

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q2 2026: Sanofi 13.284, BioNTech 0.114.

Sanofi vs BioNTech Net Worth and Market Cap

Sanofi (SNY) and BioNTech (BNTX) are peers in Vaccines. Sanofi reported revenue of $13.3B as of Q2 2026, compared with $114M for BioNTech. Sanofi leads on revenue.

Sanofi's gross margin is 75.5% versus 8.1% for BioNTech. Sanofi's net margin is 2.8% versus -777.3% for BioNTech.

Key differences

  • Revenue growth from Q2 2025 to Q2 2026: Sanofi +14.6%, BioNTech -59.6%.
  • Sanofi made an operating profit in its latest quarter (19.4% margin); BioNTech made an operating loss (-897.8%).
  • Sanofi's KPIs on Sterling include Beyfortus Net Sales (Quarterly) and Dupixent Net Sales by Region (Quarterly).
  • BioNTech's KPIs on Sterling include Cash, Cash Equivalents, and Security Investments (Quarterly) and COMIRNATY Doses as Printed.

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, Sanofi, BioNTech.
MetricSanofiBioNTech
Market Cap--
Revenue$13.28B$114.00M
Cost of Revenue$3.26B$105.00M
Gross Profit$10.03B$9.00M
Operating Income$2.58B$-1.02B
Net Income$370.00M$-886.00M
R&D Expense$2.41B$595.00M
Earnings Per Share$0.15-$3.5
Gross Margin75.5%8.1%
Operating Margin19.4%-897.8%
Net Profit Margin2.8%-777.3%
Free Cash Flow$4.22B$-48.00M
Cumulative Free Cash Flow$51.81B$19.56B
Operating Cash Flow$5.85B$12.00M
Cash & Equivalents$6.86B$10.52B

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites